Open AccessImmunotherapy with isoprinosine as an adjuvant or independent method of treatment for patientswith papilloma viral infection
Author(s) -
А М Соловьев,
A M SOLOVIYOV
Publication year - 2011
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv1086
Subject(s) - medicine , adjuvant , immunotherapy , papilloma , drug , adjuvant therapy , oncology , immunology , chemotherapy , cancer , pharmacology , pathology
Isoprinosine (an immunotropic drug) has been well-known since the 1970s and is registered in most European countries.One of indications for its use is treatment of patients with papilloma viral infection. This article describes methodsand efficacy of using Isoprinosine for such patients. The drug is administered as an adjuvant therapy in addition todestructive treatment methods or as a monotherapy. The literature review given in the article shows that the use ofIsoprinosine increases the efficacy of destructive treatment methods, reduces the frequency of recurrences, normalizesthe morphological picture of exocervix and endocervix, and results in the termination of the release of human papillomavirus from lesions.